½ÃÀ庸°í¼­
»óǰÄÚµå
1297828

¼¼°èÀÇ ¼ÒÈ­±â ³»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ½ÃÀå(2023-2030³â)

Global GI Endoscopy Guidewire Market - 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½ÃÀå °³¿ä

¼ÒÈ­±â ³»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ¼¼°è ½ÃÀåÀº 2022³â 2¾ï 5,750¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2030³â¿¡´Â 3¾ï 4,990¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ÒÈ­±â ³»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È 4.5%ÀÇ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°¡À̵å¿ÍÀ̾î´Â ´Ù¾çÇÑ ±æÀÌ¿Í Á÷°æÀ¸·Î Á¦°øµÇ¸ç Á¾Á¾ ½ºÅ×Àη¹½º ½ºÆ¿ ¶Ç´Â ÀÌ¿Í µ¿µîÇÑ Àç·á·Î ±¸¼ºµË´Ï´Ù. ³»½Ã°æÀÇ ºÎ¼Ó ä³Î ¶Ç´Â ÀÛ¾÷ ä³ÎÀ» ÅëÇØ »ðÀÔµÇ¾î ³»½Ã°æ Àǻ簡 °¡À̵å¿ÍÀ̾ ¼ÒÈ­°ü ³» ¸ñÇ¥ ºÎÀ§·Î ÁøÇàÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼ÒÈ­±â Áúȯ °ËÁø Áõ°¡·Î ¿¹Ãø ±â°£ µ¿¾È ¼ÒÈ­±â ³»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ¼¼°è ½ÃÀå ¼ºÀåÀ» ÃËÁø

ƯÈ÷ ´ëÀå¾Ï °ËÁøÀ²ÀÇ Áõ°¡´Â ¼ÒÈ­±â ÁúȯÀÇ Á¶±â ¹ß°ß°ú °ËÁøÀÇ °¡Ä¡¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁø °á°úÀÔ´Ï´Ù. °¡À̵å¿ÍÀ̾îÀÇ »ç¿ëÀº ´ëÀå ³»½Ã°æ °Ë»ç¿Í °°Àº ¼±º° °Ë»ç¿¡¼­ ÀÚÁÖ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼ú¿¡¼­ °¡À̵å¿ÍÀ̾îÀÇ Çʿ伺Àº °ËÁøÀ²ÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áõ°¡ÇÕ´Ï´Ù.

¼ÒÈ­±â ³»½Ã°æ °Ë»ç¿¡¼­ ÀÌ»óÀÌ ¹ß°ßµÇ¸é °æ¿ì¿¡ µû¶ó Ä¡·áÀû Á¶Ä¡°¡ ÇÊ¿äÇÒ ¼öµµ ÀÖ½À´Ï´Ù. »ý°Ë °âÀÚ, ¿ëÁ¾ ÀýÁ¦¿ë ¿Ã°¡¹Ì, ÇùÂø ¹× ÇùÂø¿ë ½ºÅÙÆ® µîÀÇ Ä¡·á µµ±¸´Â ¸ðµÎ °¡À̵å¿ÍÀ̾î·Î À¯µµ ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ä¡·áÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä¿Í °¡À̵å¿ÍÀ̾îÀÇ »ç¿ëÀº ¸ðµÎ °ËÁøÀ²ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áõ°¡ÇÕ´Ï´Ù.

ÀÎ½Ä ¹× ±³À° Çâ»óÀ¸·Î ¼ÒÈ­±â ³»½Ã°æ¿ë °¡À̵å¿ÍÀÌ¾î ½ÃÀå ¼ºÀå ±âȸ Á¦°ø

¼ÒÈ­±â ³»½Ã°æ¿ë °¡À̵å¿ÍÀ̾îÀÇ »ç¿ë Áõ°¡´Â ´ëÀå¾Ï°ú °°Àº ¼ÒÈ­±â ÁúȯÀ» ´ë»óÀ¸·Î ÇÑ È°µ¿ÀÇ °á°úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î±×·¥¿¡´Â °ËÁø Ä·ÆäÀÎ, °øÁߺ¸°Ç Ä·ÆäÀÎ, ÀÌÇØ°ü°èÀÚ ¹× ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ ÆÄÆ®³Ê½Ê µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Ä·ÆäÀÎÀº ÀÎÁöµµ¸¦ ³ôÀ̰í Á¶±â ¹ß°ßÀ» Àå·ÁÇÔÀ¸·Î½á ´õ ¸¹Àº »ç¶÷µéÀÌ ¼ÒÈ­±â ³»½Ã°æ °Ë»ç¸¦ ¹Þµµ·Ï Àå·ÁÇϰí ÀÖÀ¸¸ç, ¿©±â¿¡´Â °¡À̵å¿ÍÀ̾ ÇÊ¿äÇÑ °æ¿ìµµ Æ÷ÇԵ˴ϴÙ. ³»½Ã°æÀº ¾î·Á¿î ÁúȯÀ» Ä¡·áÇÏ´Â µ¿¾È °¡À̵å¿ÍÀ̾ ÅëÇØ À¯µµµÇ¾î Á¤È®ÇÑ ½Ã°¢È­¿Í È®½ÇÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¼ÒÈ­±â ³»½Ã°æ °¡À̵å¿ÍÀ̾ ´ëÇÑ ¼ö¿ä´Â ÁýÁßÀûÀÎ ³ë·ÂÀÌ È®»êµÊ¿¡ µû¶ó Áõ°¡ÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ¼ÒÈ­±â ÁúȯÀÇ Á¶±â Ä¡·á¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

COVID-19 ¿µÇ⠺м®

COVID-19ÀÇ À¯ÇàÀº ¼ÒÈ­±â ³»½Ã°æ °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, COVID-19ÀÇ ´ëÀ¯ÇàÀ¸·Î ÀÎÇØ ÀÇ·á ½Ã¼³ÀÇ ¾ÈÀü°ú °¨¿° ÅëÁ¦¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ³»½Ã°æ ½Ã¼³°ú º´¿øÀº °³Àκ¸È£±¸(PPE) »ç¿ë Áõ°¡, ¼¼Ã´ ÀýÂ÷ °³¼±, ȯÀÚ È帧 ÀýÂ÷ º¯°æ µî º¸´Ù ¾ö°ÝÇÑ Á¶Ä¡¸¦ ÃëÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Á¶Ä¡´Â ÀÇ·á ½Ã¼³ÀÇ ºñ¿ë°ú ¹°·ù ¹®Á¦¸¦ Áõ°¡½ÃÄÑ °¡À̵å¿ÍÀ̾îÀÇ ¼ö¿ë°ú »ç¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀï ºÐ¼®

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀïÀÌ ¼ÒÈ­±â ³»½Ã°æ °¡À̵å¿ÍÀÌ¾î ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº º¹ÀâÇÏ°í ´Ù¸éÀûÀÔ´Ï´Ù. Æø·Â »çÅ·ΠÀÎÇØ ÇÇÇØ Áö¿ª¿¡¼­´Â ÀÇ·á ½Ã½ºÅÛÀÌ Å©°Ô È¥¶õ½º·¯¿öÁ³½À´Ï´Ù. º´¿ø ¹× ±âŸ ÀÇ·á ±â°ü¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¼Õ»óµÇ¾î ³»½Ã°æ Ä¡·á ¹× °¡À̵å¿ÍÀ̾î¿Í °°Àº °ü·Ã ÀåºñÀÇ È¹µæ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÃÖ¼Òħ½À Ä¡·á ä¿ë Áõ°¡
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
      • ÈÆ·ÃÀ» ¹ÞÀº Àü¹®°¡ ºÎÁ·
    • ±âȸ
      • ±â¼ú Áøº¸
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ¹ÌÃæÁ· ¼ö¿ä
  • ±ÔÁ¦ ºÐ¼®

Á¦6Àå COVID-19 ºÐ¼®

Á¦7Àå ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀï ºÐ¼®

Á¦8Àå Àΰø Áö´É ºÐ¼®

Á¦9Àå ¼ÒÀ纰

  • ½ºÅ×Àθ®½º
  • ´ÏƼ³î
  • ±âŸ

Á¦10Àå ÀûÀÀÁõº°

  • ERCP
  • »óºÎ À§³»½Ã°æ °Ë»ç
  • ÃÊÀ½ÆÄ ³»½Ã°æ(EUS)
  • ´ëÀå³»½Ã°æ °Ë»ç

Á¦11Àå µðÀÚÀκ°

  • ¸ð³ëÇʶó¸àÆ® ¿ÍÀ̾î
  • ÄÚÀÏ ¿ÍÀ̾î
  • ÇǺ¹ ¿ÍÀ̾î

Á¦12Àå ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ¿¬±¸¼Ò¡¤Çмú±â°ü
  • ±âŸ

Á¦13Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦14Àå °æÀï »óȲ

  • °æÀï ½Ã³ª¸®¿À
  • Á¦Ç° º¥Ä¡¸¶Å©
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ¹ßÀü°ú Àü·«

Á¦15Àå ±â¾÷ °³¿ä

  • Boston Scientific Corporation
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • CONMED Corporation
  • COOK MEDICAL Inc
  • HOBBS MEDICAL INC
  • Olympus Corporation
  • Medico's-Hirata Inc
  • Sumitomo Bakelite Co., Ltd
  • Diagmed Healthcare
  • Omnimed Ltd
  • Merit medical systems, Inc

Á¦16Àå ºÎ·Ï

ksm 23.07.11

Market Overview

The Global GI Endoscopy Guidewire Market reached US$ 257.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 349.9 million by 2030. The Global GI Endoscopy Guidewire Market is expected to exhibit a CAGR of 4.5% during the forecast period (2023-2030).

The guidewire comes in a variety of lengths and diameters and is often composed of stainless steel or comparable material. It is inserted through an accessory channel or working channel of the endoscope, allowing the endoscopist to advance it into the targeted area within the GI tract.

Market Dynamics

Increasing Screening for GI Diseases Are Boosting The Global GI Endoscopy Guidewire Market Growth During The Forecast Period.

Increased screening rates, particularly for colorectal cancer, are the result of growing public awareness of the value of early identification and screening for GI diseases. The use of guidewires is frequently necessary during screening procedures like colonoscopies, which are advised for those over a certain age or who have a certain set of risk factors. The need for guidewires in these operations rises as screening rates do.

Therapeutic measures may be necessary in some instances if GI endoscopic tests reveal abnormalities. Therapeutic tools like biopsy forceps, snares for removing polyps, or stents for narrowing or strictures can all be guided by guidewires. The demand for therapeutic interventions and the use of guidewires both rise with higher screening rates.

Increasing Awareness And Education Provide GI Endoscopy Guidewire With Market Growth Opportunities.

The rising use of GI endoscopy guidewires is a result of targeted activities for GI disorders such as colorectal cancer. These programs include screening campaigns, public health campaigns, and stakeholder and healthcare provider partnerships. These campaigns encourage more people to have GI endoscopy procedures, including those requiring guidewires, by increasing awareness and encouraging early detection. Endoscopes are guided by guidewires during therapeutic treatments in difficult cases, enabling precise visualization and reliable diagnosis. The need for GI endoscopic guidewires is anticipated to increase as focused initiatives spread, promoting better patient outcomes and the early treatment of GI disorders.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the GI Endoscopy Guidewire market. The COVID-19 pandemic increased worries about safety and infection control in healthcare facilities. Stricter measures were put in place by endoscopy facilities and hospitals, including increased use of personal protective equipment (PPE), improved cleaning procedures, and altered patient flow procedures. Although required, these actions increased expenses and logistical difficulties for healthcare facilities, which can have an impact on guidewire acceptance and use.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the GI endoscopy guidewire market is complex and multifaceted. In the impacted areas, the violence has severely disrupted the healthcare system. The accessibility of hospitals and other medical institutions may have been compromised, affecting the availability of endoscopic treatments and associated equipment, such as guidewires.

Segment Analysis

The global GI endoscopy guidewire market is segmented based on material, indication, design, end-user, and region.

The Colonoscopy Segment Is Expected To Hold A Dominant Position In The Market Over The Forecast Period.

The colonoscopy segment accounted for the highest market stake accounting for approximately 39.6% of the GI endoscopy guidewire market in 2022. The large intestine (colon) is examined using a colonoscopy, a frequent diagnostic and therapeutic technique, to look for anomalies including polyps, tumors, or inflammation. Although they are not frequently utilized in colonoscopies, guidewires may be used in some circumstances. A guidewire may occasionally be used during a colonoscopy to help the endoscope pass through difficult anatomical variations, strictures, or convoluted sections of the colon. The endoscope can be guided and advanced through the colon with the aid of the guidewire.

Geographical Analysis

Increasing Collaborations And Partnerships Among The Key Players, And Advancement in GI Endoscopy Guidewire Dominate the European Region.

Europe is expected to dominate the GI endoscopy guidewire market, accounting for around 26.8% of this market. The market players are offering the products in the region to strengthen their business in the European region. For instance, the Barr 360 express RFA balloon catheter, Barr 360 RFA balloon catheter, and the Barr 360 soft-sizing balloon can all be exchanged with the use of Barr RFA endoscopic guidewires.

Competitive Landscape

The major global players in the market include: Boston Scientific Corporation, CONMED Corporation, COOK MEDICAL Inc, HOBBS MEDICAL INC, Olympus Corporation, Medico's-Hirata Inc, Sumitomo Bakelite Co., Ltd, Diagmed Healthcare, Omnimed Ltd, and Merit medical systems among others.

Why Purchase the Report?

  • To visualize the global GI endoscopy guidewire market segmentation based on the material, indication, design, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous GI endoscopy guidewire market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global GI endoscopy guidewire market report would provide approximately 68 tables, 69 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material
  • 3.2. Snippet by Indication
  • 3.3. Snippet by Design
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising adoption of minimally invasive therapies
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of trained professionals
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. Stainless Steel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Nitinol
  • 9.4. Others

10. By Indication

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.1.2. Market Attractiveness Index, By Indication
  • 10.2. ERCP*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Upper-GI endoscopy
  • 10.4. Endoscopic Ultrasound (EUS)
  • 10.5. Colonoscopy

11. By Design

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 11.1.2. Market Attractiveness Index, By Design
  • 11.2. Monofilament Wires*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Coiled Wires
  • 11.4. Coated or Sheathed Wires

12. By End-user

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 12.1.2. Market Attractiveness Index, By End-user
  • 12.2. Hospitals*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Research Laboratories & Academic Institutes
  • 12.4. Others

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. The U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. The U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Spain
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Product Benchmarking
  • 14.3. Company Share Analysis
  • 14.4. Key Developments and Strategies

15. Company Profiles

  • 15.1. Boston Scientific Corporation*
    • 15.1.1. Company Overview
    • 15.1.2. Product Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. CONMED Corporation
  • 15.3. COOK MEDICAL Inc
  • 15.4. HOBBS MEDICAL INC
  • 15.5. Olympus Corporation
  • 15.6. Medico's-Hirata Inc
  • 15.7. Sumitomo Bakelite Co., Ltd
  • 15.8. Diagmed Healthcare
  • 15.9. Omnimed Ltd
  • 15.10. Merit medical systems, Inc

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦